Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Jun 1;26(6):e816-e826.
doi: 10.1097/PCC.0000000000003737. Epub 2025 Apr 2.

Time Course of Kidney Injury Biomarkers in Children With Septic Shock: Nested Cohort Study Within the Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis Trial

Collaborators, Affiliations
Multicenter Study

Time Course of Kidney Injury Biomarkers in Children With Septic Shock: Nested Cohort Study Within the Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis Trial

Scott L Weiss et al. Pediatr Crit Care Med. .

Abstract

Objective: Severe acute kidney injury (AKI) portends poor outcomes in pediatric sepsis. We evaluated the trajectory and prognostic utility of AKI biomarkers in pediatric septic shock using a subset of participants in the ongoing Pragmatic Pediatric Trial of Balanced vs. Normal Saline Fluid in Sepsis (PRoMPT BOLUS) trial, NCT04102371. We tested whether fluid volume is associated with persistent elevation of urine neutrophil gelatinase-associated lipocalin (Ur-NGAL).

Design: Prospective, non-prespecified cohort study within the PRoMPT BOLUS trial.

Setting: Three children's hospitals in the United States.

Patients: Four hundred seventy-eight patients aged 2 months to younger than 18 years old with septic shock.

Interventions: None.

Measurements and main results: Ur-NGAL, kidney injury molecule-1, liver fatty acid binding protein, and interleukin-18 and plasma cystatin C were collected at presentation (T1), days 2-3 (T2), and before discharge/death (T3). At presentation, 418 (88%) had no or only stage 1 AKI and 60 (12%) had stage 2/3 AKI defined using Kidney Disease Improving Global Outcomes creatinine thresholds. All biomarkers were higher with stage 2/3 compared with no/stage 1 AKI at T1 and T2, but only cystatin C remained higher at T3. Among patients with no/stage 1 AKI at presentation, those with Ur-NGAL greater than or equal to 150 vs. less than 150 ng/mL had fewer hospital-free days (21 [interquartile range (IQR) 15-24] vs. 23 d [IQR 19-25], p = 0.05). After applying inverse probability treatment weighting to balance covariates, 14% of patients who received greater than 100 mL/kg within 48 hours had persistently elevated Ur-NGAL over time compared with 6% who received 40-100 mL/kg (odds ratio 2.7 [95% CI, 1.1-6.2]). Hospital-free days were no different across fluid volume groups.

Conclusions: Although kidney injury biomarkers mirrored serum creatinine in children with septic shock, elevated Ur-NGAL identified a subset with subclinical AKI with fewer hospital-free days despite no/stage 1 AKI by creatinine. Children receiving greater than 100 mL/kg fluid had greater odds of early and persistently elevated Ur-NGAL, suggesting high fluid volumes may perpetuate initial kidney damage.

Keywords: acute kidney injury; biomarkers; child; resuscitation; sepsis.

PubMed Disclaimer

Conflict of interest statement

Dr. Fitzgerald received research grant support from BioPorto unrelated to the current study. Dr. Weiss’ institution received funding from the Pennsylvania Department of Health Formula (4100085749), the National Institute of Child Health and Human Development (NICHD) (R01HD101528), and the National Institute of General Medical Sciences (NIGMS) (R01GM145698). Drs. Weiss, Fitzgerald, Singh, Artis, Tsemberis, Campos, C. Hickey, Eckerle, R.W. Hickey, Kuppermann, and Balamuth received support for article research from the National Institutes of Health (NIH). Dr. Fitzgerlad’s institution received funding from the Commonwealth of Pennsylvania CURE Grant and BioPorto. Drs. Artis’, Campos’, and Balamuth’s institutions received funding from the NIH. Dr. Artis’ institution received funding from the Pennsylvania Department of Health. Drs. Campos’ and Balamuth’s institutions received funding from the Commonwealth of Pennsylvania. Dr. C. Hickey’s institution received funding from CURE. Dr. R.W. Hickey’s institution received funding from the Pennsylvania Department of Health and the NIGMS. Dr. Kuppermann’s institution received funding from the NICHD. Dr. Balalmuth’s institution received funding from Emergency Medical Services for Children. The remaining authors have disclosed that they do not have any potential conflicts of interest.

References

    1. Schlapbach LJ, Watson RS, Sorce LR, et al.: International Consensus Criteria for Pediatric Sepsis and Septic Shock. JAMA 2024; 331:665–674 - PMC - PubMed
    1. Fitzgerald JC, Basu RK, Akcan-Arikan A, et al.: Acute Kidney Injury in Pediatric Severe Sepsis: An Independent Risk Factor for Death and New Disability. Crit Care Med 2016; 44:2241–2250 - PMC - PubMed
    1. Fitzgerald JC, Ross ME, Thomas NJ, et al.: Risk factors and inpatient outcomes associated with acute kidney injury at pediatric severe sepsis presentation. Pediatr Nephrol 2018; 33:1781–1790 - PubMed
    1. Kaddourah A, Basu RK, Bagshaw SM, et al.: Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults. N Engl J Med 2017; 376:11–20 - PMC - PubMed
    1. Basu RK, Kaddourah A, Terrell T, et al.: Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in Critically Ill Children (AWARE): A Prospective Study to Improve Diagnostic Precision. J Clin Trials 2015; 5 - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources